Iliac crest bone mass and remodelling in acromegaly.

Iliac crest bone biopsies from 18 patients with active acromegaly, of whom 11 had received tetracycline double-labelling, were evaluated by quantitative histomorphometry and compared with age- and sex-matched normal controls. A significant increase (P less than 0.01) was found in both cortical (175%) and trabecular (130%) bone mass. In trabecular bone, resorption surfaces and active (tetracycline-labelled) and total formation surfaces were increased (P less than 0.05 and P less than 0.01, respectively) causing an enhanced bone turn-over at tissue level (P less than 0.01). The increased trabecular bone mass indicates a positive net balance per remodelling cycle and, therefore, larger than normal bone remodelling units, which in part may explain the increased bone turn-over at tissue level. The activity of the osteoblasts active in mineralization (the appositional rate) was increased (P less than 0.01) and positively related to the fasting serum growth hormone levels (Rs = 0.69, P less than 0.05). The average activity of active and inactive osteoblasts (bone formation rate at basic metabolic unit (BMU) level) was insignificantly increased. The proportion of active (tetracycline labelled) to nonactive formation surfaces was normal. The bone changes were unrelated to serum levels and urinary excretions of calcium and phosphorus or to renal excretion of total and non-dialyzable hydroxyproline or cAMP.

[1]  J. Halse,et al.  [Urinary cyclic AMP in primary hyperparathyroidism]. , 1982, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[2]  J. Halse,et al.  Total and non-dialyzable urinary hydroxyproline in acromegalics and control subjects. , 1981, Acta endocrinologica.

[3]  J. Halse,et al.  Calcium and phosphate metabolism in acromegaly. , 1980, Acta endocrinologica.

[4]  J. Halse Urinary 3',5'-cyclic adenosine monophosphate in relation to serum and urinary calcium in acromegaly and primary hyperparathyroidism. , 1980, Acta endocrinologica.

[5]  D. Brown,et al.  Role of pituitary hormones in regulating renal vitamin D metabolism in man. , 1980, British medical journal.

[6]  A. Norman,et al.  Acromegaly and vitamin D metabolism: effect of bromocriptine treatment. , 1979, The Journal of clinical endocrinology and metabolism.

[7]  J. Halse,et al.  Urinary hydroxyproline excretion in acromegaly. , 1978, Acta endocrinologica.

[8]  J. Halse,et al.  A simple procedure for the determination of hydroxyproline in urine and bone. , 1978, Biochemical medicine.

[9]  F. Melsen,et al.  Histomorphometric Analysis of Normal Bone From the Iliac Crest , 1978, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

[10]  J. Halse,et al.  Bromocriptine treatment in acromegaly: clinical and biochemical effects. , 1977, Acta endocrinologica.

[11]  K. Ntalles,et al.  Cortical Bone Mass in Acromegaly , 1974, Acta radiologica: diagnosis.

[12]  P. Kelly,et al.  The nature of the metabolic bone disorder in acromegaly. , 1972, The Journal of laboratory and clinical medicine.

[13]  J. Dequeker Periosteal and endosteal surface remodeling in pathologic conditions. , 1971, Investigative radiology.

[14]  S. Garn The earlier gain and the later loss of cortical bone, in nutritional perspective , 1970 .

[15]  F. Doyle Radiology of the skeleton in endocrine diseases. , 1967, Proceedings of the Royal Society of Medicine.

[16]  H. Frost,et al.  Tetracycline‐Based Measurement of the Tissue and Cell Dynamics in Rib of a 25‐Year-Old Man With Active Acromegaly , 1966, Clinical orthopaedics and related research.

[17]  G. Gordan,et al.  Skeletal dynamics in man measured by nonradioactive strontium. , 1961, The Journal of clinical investigation.